Source: Aigenerated

Scorpio Gold Corporation (TSXV: SGLD) trading resumes at 2:45 p.m. ET, CIRO says

Scorpio Gold Corporation News: Key Takeaways

  • Trading in Scorpio Gold Corporation shares is scheduled to resume at 2:45 p.m. ET, according to the Canadian Investment Regulatory Organization (CIRO).
  • The notice applies to all issues under the TSX Venture symbol SGLD.
  • CIRO said it may impose temporary trading suspensions to support a fair and orderly market.

What Happened?

The Canadian Investment Regulatory Organization (CIRO) published a halts/resumptions notice stating that trading will resume in Scorpio Gold Corporation under the TSX Venture Exchange symbol SGLD. The notice indicates the resumption time as 2:45 p.m. ET and specifies that it applies to all issues.

CIRO noted that trading halts can be used to help ensure a fair and orderly market and that it oversees investment dealers and trading activity on Canadian debt and equity marketplaces.

Why This Matters for Investors

A resumption notice indicates the company's shares are expected to return to active trading after a halt, which can affect liquidity and price discovery. The CIRO bulletin does not provide details on the reason for the preceding halt or any related company-specific developments.

The original press release is available on stockhouse.com

More From The Market Online

Scribe starts Phase 1 trial for cholesterol drug STX-1150

Scribe Therapeutics Inc. (NASDAQ: SCTX) reports Q2 2026 results, starts Phase 1 for STX-1150, and outlines post-IPO cash runway Scribe Therapeutics Inc. (NASDAQ: SCTX)…

Superior Group to attend two September investor events

Superior Group of Companies, Inc. (NASDAQ: SGC) to present at two September virtual investor conferences Superior Group of Companies News: Key Takeaways Superior Group…

Attovia flags ATTO-1310 itch data, Phase 1b readout Q4

Attovia Therapeutics, Inc. (NASDAQ: ATTO) reports Q2 2026 results, highlights ATTO-1310 Phase 1b progress and post-IPO cash runway Attovia Therapeutics, Inc. (NASDAQ: ATTO) reported…

Zentalis to present at Wells Fargo, Morgan Stanley events

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) to Present at Wells Fargo and Morgan Stanley Healthcare Conferences Zentalis Pharmaceuticals News: Key Takeaways Zentalis Pharmaceuticals, Inc. will…